Globus Medical operates as a publicly traded corporation listed on the New York Stock Exchange under the ticker symbol GMED, meaning it is owned collectively by its widespread shareholder base rather than an individual private proprietor. The vast majority of common stock is held by prominent institutional investment firms, large-scale asset management complexes, mutual fund managers, and index fund providers. While executive officers, board members, and founder David C. Paul retain significant equity stakes and insider shares, institutional public ownership dictates overall corporate governance.